These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33625141)

  • 1. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
    Steinsapir KD; Steinsapir SMG
    Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
    Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
    Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latisse: empirical discovery yields treatment for sparse eyelashes.
    Woodson SA
    Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
    Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
    Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
    Fagien S
    Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eyelash serums: A comprehensive review.
    Baiyasi M; St Claire K; Hengy M; Tur K; Fahs F; Potts G
    J Cosmet Dermatol; 2024 Jul; 23(7):2328-2344. PubMed ID: 38475901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Evaluation of Topical Bimatoprost and Iris Pigmentation Change.
    Zaleski-Larsen LA; Ruth NH; Fabi SG
    Dermatol Surg; 2017 Dec; 43(12):1431-1433. PubMed ID: 28562438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
    Barrón-Hernández YL; Tosti A
    Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse periocular reactions to five types of prostaglandin analogs.
    Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
    Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimatoprost in the treatment of eyelash hypotrichosis.
    Law SK
    Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
    Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
    Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
    Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
    Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
    Ahluwalia GS
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced eyelashes: prescription and over-the-counter options.
    Jones D
    Aesthetic Plast Surg; 2011 Feb; 35(1):116-21. PubMed ID: 20730536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
    Fagien S
    Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latisse (bimatoprost) for enhancement of eyelashes.
    Flaharty PM; Flaharty KK; Gorman L
    Insight; 2014; 39(3):24-6. PubMed ID: 25195339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.